Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer

While biologics have been successfully applied in TNF antagonist treatments, there are no clinically approved small molecules that target TNF. Here, the authors discover potent small molecule inhibitors of TNF, elucidate their molecular mechanism, and demonstrate TNF inhibition in vitro and in vivo.

Guardado en:
Detalles Bibliográficos
Autores principales: James O’Connell, John Porter, Boris Kroeplien, Tim Norman, Stephen Rapecki, Rachel Davis, David McMillan, Tracy Arakaki, Alex Burgin, David Fox III, Tom Ceska, Fabien Lecomte, Alison Maloney, Alex Vugler, Bruce Carrington, Benjamin P Cossins, Tim Bourne, Alastair Lawson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/cd8aea08c83948d3a69fc5302494dedc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd8aea08c83948d3a69fc5302494dedc
record_format dspace
spelling oai:doaj.org-article:cd8aea08c83948d3a69fc5302494dedc2021-12-02T17:01:34ZSmall molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer10.1038/s41467-019-13616-12041-1723https://doaj.org/article/cd8aea08c83948d3a69fc5302494dedc2019-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-13616-1https://doaj.org/toc/2041-1723While biologics have been successfully applied in TNF antagonist treatments, there are no clinically approved small molecules that target TNF. Here, the authors discover potent small molecule inhibitors of TNF, elucidate their molecular mechanism, and demonstrate TNF inhibition in vitro and in vivo.James O’ConnellJohn PorterBoris KroeplienTim NormanStephen RapeckiRachel DavisDavid McMillanTracy ArakakiAlex BurginDavid Fox IIITom CeskaFabien LecomteAlison MaloneyAlex VuglerBruce CarringtonBenjamin P CossinsTim BourneAlastair LawsonNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
James O’Connell
John Porter
Boris Kroeplien
Tim Norman
Stephen Rapecki
Rachel Davis
David McMillan
Tracy Arakaki
Alex Burgin
David Fox III
Tom Ceska
Fabien Lecomte
Alison Maloney
Alex Vugler
Bruce Carrington
Benjamin P Cossins
Tim Bourne
Alastair Lawson
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
description While biologics have been successfully applied in TNF antagonist treatments, there are no clinically approved small molecules that target TNF. Here, the authors discover potent small molecule inhibitors of TNF, elucidate their molecular mechanism, and demonstrate TNF inhibition in vitro and in vivo.
format article
author James O’Connell
John Porter
Boris Kroeplien
Tim Norman
Stephen Rapecki
Rachel Davis
David McMillan
Tracy Arakaki
Alex Burgin
David Fox III
Tom Ceska
Fabien Lecomte
Alison Maloney
Alex Vugler
Bruce Carrington
Benjamin P Cossins
Tim Bourne
Alastair Lawson
author_facet James O’Connell
John Porter
Boris Kroeplien
Tim Norman
Stephen Rapecki
Rachel Davis
David McMillan
Tracy Arakaki
Alex Burgin
David Fox III
Tom Ceska
Fabien Lecomte
Alison Maloney
Alex Vugler
Bruce Carrington
Benjamin P Cossins
Tim Bourne
Alastair Lawson
author_sort James O’Connell
title Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
title_short Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
title_full Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
title_fullStr Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
title_full_unstemmed Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
title_sort small molecules that inhibit tnf signalling by stabilising an asymmetric form of the trimer
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/cd8aea08c83948d3a69fc5302494dedc
work_keys_str_mv AT jamesoconnell smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT johnporter smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT boriskroeplien smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT timnorman smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT stephenrapecki smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT racheldavis smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT davidmcmillan smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT tracyarakaki smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT alexburgin smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT davidfoxiii smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT tomceska smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT fabienlecomte smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT alisonmaloney smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT alexvugler smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT brucecarrington smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT benjaminpcossins smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT timbourne smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
AT alastairlawson smallmoleculesthatinhibittnfsignallingbystabilisinganasymmetricformofthetrimer
_version_ 1718382112706396160